门诊药剂师策略改善了血管疾病患者的指导方针坚持药物处方
Aaron Tran1, Alexandra Lotric2, Lauren Hunt2
1Department of Vascular Surgery, The Alfred, Alfred Health, Melbourne, Victoria, Australia.
概括
将临床药剂师纳入血管诊所显著改善了高强度他类药物处方和戒烟干预措施. 这一策略增强了血管疾病患者的医疗治疗,改善了对指导方针的遵守.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 血管疾病的最佳医学治疗包括降脂,抗血小板和戒烟策略.
- 在血管疾病患者中,这些必需疗法的处方率往往低于最佳水平.
- 临床药剂师可以在优化专门诊所的患者护理方面发挥至关重要的作用.
研究的目的:
- 评估将临床药剂师整合到门诊血管诊所的影响.
- 评估对他类药物和抗血小板药物处方的变化.
- 为了确定患有血管疾病的患者的戒烟干预措施的影响.
主要方法:
- 一项前性,单中心的队列试点研究,将药剂师干预 (2023年6月至12月) 与历史对照 (2022年7月至12月) 进行比较.
- 包括患有下肢动脉疾病,动脉疾病和大动脉动脉瘤的患者用于药物分析.
- 包括所有目前的吸烟者进行戒烟干预分析;用于评估结果的后勤回归.
主要成果:
- 药剂师审查与增加高强度他类药物处方 (AOR 3.38 ,p < .001) 有关.
- 在抗血小板处方方面没有发现显著的关联 (AOR 0.66,p = .30).
- 药剂师评价与尼古丁替代疗法处方 (OR 3.98,p = .008) 和戒烟转诊 (OR 19.20,p < .001) 有很强的相关性.
结论:
- 将临床药剂师整合到门诊血管诊所中,可以改善符合指导方针的他类药物治疗处方.
- 药剂师的参与增强了血管病患者的戒烟服务提供.
- 这一策略代表了一种有效的方法,用于优化血管疾病管理中的医疗治疗.
更多相关视频
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
30
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
30
01:23Peripheral Artery Disease V: Postoperative Nursing Management
26
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
26
01:29Venous Thrombosis III: Interprofessional Care
25
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
25
01:26Atherosclerosis III: Management
40
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
40
01:26Peripheral Artery Disease IV: Nursing Management
46
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
46
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
46
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
46